|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
2,250,000,000 |
Market
Cap: |
91.01(B) |
Last
Volume: |
18,277,023 |
Avg
Vol: |
12,077,193 |
52
Week Range: |
$40.25 - $64.73 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 100 |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 97 |
Guru Rank Value : 8.6 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
13,571 |
13,571 |
Total Buy Value |
$0 |
$0 |
$672,994 |
$672,994 |
Total People Bought |
0 |
0 |
2 |
2 |
Total Buy Transactions |
0 |
0 |
3 |
3 |
Total Shares Sold |
0 |
0 |
18,718 |
616,397 |
Total Sell Value |
$0 |
$0 |
$1,146,397 |
$44,859,834 |
Total People Sold |
0 |
0 |
2 |
5 |
Total Sell Transactions |
0 |
0 |
2 |
11 |
End Date |
2024-04-04 |
2024-01-02 |
2023-07-04 |
2022-07-04 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Elicker John E |
SVP Pub Affairs & Inv Relation |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,360 |
51,827 |
|
- |
|
Leung Sandra |
General Counsel & Secretary |
|
2015-03-02 |
4 |
D |
$62.30 |
$1,424,053 |
D/D |
(22,858) |
293,397 |
|
- |
|
Leung Sandra |
General Counsel & Secretary |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
44,084 |
316,255 |
|
- |
|
Andreotti Lamberto |
Chief Executive Officer |
|
2015-03-02 |
4 |
D |
$62.30 |
$8,044,488 |
D/D |
(129,125) |
514,839 |
|
- |
|
Andreotti Lamberto |
Chief Executive Officer |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
231,280 |
643,964 |
|
- |
|
Elicker John E |
SVP Pub Affairs & Inv Relation |
|
2015-03-02 |
4 |
D |
$62.30 |
$156,435 |
D/D |
(2,511) |
58,098 |
|
- |
|
Elicker John E |
SVP Pub Affairs & Inv Relation |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,250 |
60,609 |
|
- |
|
Nielsen Anne |
Chief Compliance & Ethics Off |
|
2015-03-02 |
4 |
D |
$62.30 |
$147,651 |
D/D |
(2,370) |
47,908 |
|
- |
|
Nielsen Anne |
Chief Compliance & Ethics Off |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,725 |
50,278 |
|
- |
|
Caforio Giovanni |
Chief Operating Officer |
|
2015-03-02 |
4 |
D |
$62.30 |
$687,044 |
D/D |
(11,028) |
59,097 |
|
- |
|
Caforio Giovanni |
Chief Operating Officer |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,851 |
70,125 |
|
- |
|
Caldarella Joseph C |
SVP & Controller |
|
2015-03-02 |
4 |
D |
$62.30 |
$435,664 |
D/D |
(6,993) |
72,737 |
|
- |
|
Caldarella Joseph C |
SVP & Controller |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,271 |
79,730 |
|
- |
|
Cuss Francis M |
EVP & CSO |
|
2015-03-02 |
4 |
D |
$62.30 |
$696,327 |
D/D |
(11,177) |
258,928 |
|
- |
|
Cuss Francis M |
EVP & CSO |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,803 |
270,105 |
|
- |
|
Bancroft Charles A |
EVP & Chief Financial Officer |
|
2015-03-02 |
4 |
D |
$62.30 |
$1,624,784 |
D/D |
(26,080) |
144,434 |
|
- |
|
Bancroft Charles A |
EVP & Chief Financial Officer |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,926 |
170,514 |
|
- |
|
Moed Samuel J |
SVP, Strat Plan & Analysis |
|
2015-03-02 |
4 |
D |
$62.30 |
$266,582 |
D/D |
(4,279) |
39,581 |
|
- |
|
Moed Samuel J |
SVP, Strat Plan & Analysis |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,249 |
43,860 |
|
- |
|
Von Autenried Paul |
SVP, Enterp. Services & CIO |
|
2015-03-02 |
4 |
D |
$62.30 |
$527,930 |
D/D |
(8,474) |
51,949 |
|
- |
|
Von Autenried Paul |
SVP, Enterp. Services & CIO |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,907 |
60,423 |
|
- |
|
Schmukler Louis S |
Pres., Global Mfg. & Supply |
|
2015-03-02 |
4 |
D |
$62.30 |
$414,357 |
D/D |
(6,651) |
27,525 |
|
- |
|
Schmukler Louis S |
Pres., Global Mfg. & Supply |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,995 |
34,176 |
|
- |
|
Andreotti Lamberto |
Chief Executive Officer |
|
2015-03-02 |
4 |
D |
$62.30 |
$2,332,574 |
D/D |
(37,441) |
412,684 |
|
- |
|
Andreotti Lamberto |
Chief Executive Officer |
|
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
33,531 |
450,125 |
|
- |
|
953 Records found
|
|
Page 36 of 39 |
|
|